Chiral Excellence Arran Chemical specializes in chiral chemistry employing both chemocatalysis and biocatalysis, indicating a strong capability to develop and manufacture enantioselective compounds for pharma and health care customers. Sales opportunities include partnering on complex chiral intermediates, process development, and scale-up for high-value active pharmaceutical ingredients.

Almac Integration As a member of the Almac Group, Arran Chemical benefits from a broader ecosystem and potential cross-sell with Almac’s existing customers in life sciences, formulation, and related services. Target opportunities include co-offerings, bundled solutions, and referrals to optimize supply chains for pharmaceutical development and manufacturing.

Awarded R&D The company has received a research and development award, signaling strong scientific capabilities and a proven track record in innovative chemistry solutions. Use this credibility to engage potential clients seeking advanced synthetic strategies, process optimization, and technology transfer.

Modest Revenue Current revenue is in the sub-1 million range with 51-200 employees, suggesting room for growth through expanded contract manufacturing, new product lines, and extended service offerings. Propose scalable manufacturing capacity, faster time-to-market, and selective customer onboarding to enhance top-line impact.

Diverse Markets Expertise spans pharmaceutical and health care, flavour/fragrance, personal care, and other specialised chemical applications, indicating multiple adjacency opportunities. Position as a versatile supplier for clients exploring integrated chemistry solutions, from early-stage development to finished products and regulatory-ready intermediates.